BICYCLE THERAPEUTICS PLC - BCYC
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | Armistice Capital, LLC | 6.72% | 3,398,000 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Steven Boyd | 6.72% | 3,398,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Armistice Capital, LLC | 6.75% | 3,398,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Steven Boyd | 6.75% | 3,398,000 | View |
| May 15, 2026 | SCHEDULE 13G | LONG FOCUS CAPITAL MANAGEMENT, LLC | 6.6% | 3,310,687 | View |
| May 15, 2026 | SCHEDULE 13G | JOHN HELMERS | 6.6% | 3,310,687 | View |
| May 04, 2026 | SCHEDULE 13G/A | Invus Public Equities, L.P. | 2.7% | 1,368,586 | View |
| May 04, 2026 | SCHEDULE 13G/A | Invus Public Equities Advisors, LLC | 2.7% | 1,368,586 | View |
| May 04, 2026 | SCHEDULE 13G/A | Invus Global Management, LLC | 2.7% | 1,368,586 | View |
| May 04, 2026 | SCHEDULE 13G/A | Siren, L.L.C. | 2.7% | 1,368,586 | View |
| May 04, 2026 | SCHEDULE 13G/A | Avicenna Life Sci Master Fund LP | 0.4% | 192,296 | View |
| May 04, 2026 | SCHEDULE 13G/A | Avicenna Life Sci Master GP LLC | 0.4% | 192,296 | View |
| May 04, 2026 | SCHEDULE 13G/A | Ulys, L.L.C. | 0.4% | 192,296 | View |
| May 04, 2026 | SCHEDULE 13G/A | Raymond Debbane | 3.1% | 1,560,882 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.